Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon + glyceryl trinitrate versus placebo for soft food bolus impaction
ACTRN12616001055493Phase 3Terminated
- Sponsor
- Fiona Stanley Hospital
- Start
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Esophageal food impaction comparing Glucagon + glyceryl trinitrate with Placebo (2 arms). Primary endpoint: Clinical resolution of impaction by 30 minutes. Started Mar 2018; status: terminated.
02
Drugs
glucagonnitroglycerin
03
Conditions
Esophageal food impaction
Beyond the preview
Go deeper on ACTRN12616001055493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001055493.